Granny Retail breaks down the health of consumption.In today’s video, I’m going to introduce you to my favorite way to explain markets, price action and where the market might be headed, plus cover a few technicals with you. We will talk with three finance experts within our Modern Family to find out more. Please sit...
Month: August 2022
Dividend Aristocrats In Focus: Leggett & Platt
Updated on August 31st, 2022 by Josh Arnold Every year, we review all of the Dividend Aristocrats, a group of 65 companies in the S&P 500 Index with 25+ consecutive years of dividend increases. We feel each Dividend Aristocrat deserves an individual review each year because the Dividend Aristocrats are very unique within the broader...
Australian edible gel maker Gelteq files for proposed $7M US IPO
Mikko Lemola Australian edible gel maker Gelteq (GELS) has filed for a proposed $6.5M initial public offering in the US. Gelteq said in a filing that it is looking to offer 1.3M shares at the assumed price of $5 per share, which would raise around $6.5M. Underwriters would be granted a 45-day option to buy...
Disney Reportedly Mulls Launching Amazon-Prime Rival Membership Program: DJ By Investing.com
© Reuters By Yasin Ebrahim Investing.com – Disney is reportedly mulling the launch of a membership program that could rival Amazon (NASDAQ:) Prime and encourage customers to spend more on its streaming serves, theme parks, resorts and merchandise, Dow Jones reported, citing unnamed sources. Walt Disney Company (NYSE:) was up nearly 2% in afterhours trading....
Hempacco stock slides 17% after soaring 600% in prior session following IPO (NASDAQ:HPCO)
designer491 Hemp-based cigarette maker Hempacco (NASDAQ:HPCO) stock fell 17% in midday trading Wednesday after rallying as high as 600% the previous session following the company’s $6M initial public offering. Shares of Hempacco opened at $7.16, jumping to an early high of $7.43 before dipping to a low of $6.19 in early trading. The stock recently...
U.S. FDA green lights Omicron-targeted COVID boosters ahead of revaccination campaign By Reuters
© Reuters. People pose with syringe with needle in front of displayed Moderna logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustration/Files By Michael Erman and Julie Steenhuysen (Reuters) -The U.S. Food and Drug Administration on Wednesday authorized updated COVID-19 booster shots from Pfizer/BioNTech and Moderna (NASDAQ:) that target the dominant BA.4 and BA.5...
China-focused Addentax stock soars following uplisting, $25M IPO (NASDAQ:ATXG)
2d illustrations and photos Addentax Group (NASDAQ:ATXG) shares soared following the China-focused company’s uplisting to Nasdaq and $25M initial public offering. Shares of Addentax opened at $27, reaching a high of $32.56 in early trading before sliding to a low of $12.95 in late morning. The shares recently changed hands at $25.27, up 405% from...
Shuttle Pharmaceuticals stock soars 100% following $10M IPO (NASDAQ:SHPH)
Valerii Apetroaiei Radiation therapy drug developer Shuttle Pharmaceuticals (NASDAQ:SHPH) saw its stock soar 100% following its $10M initial public offering on Wednesday. Shares of Shuttle opened at $24.05, reaching a high of $25 in early trading before dipping to a low of $13.60 mid-morning. The stock recently changed hands at $16.30 at approximately 10:50 a.m....
Morgan Stanley Expects T-Mobile to Start ‘Smaller’ With Share Buybacks By Investing.com
© Reuters. Morgan Stanley Expects T-Mobile (TMUS) to Start ‘Smaller’ With Share Buybacks By Sam Boughedda A Morgan Stanley analyst named T-Mobile (NASDAQ:) a catalyst driven idea as it expects the company to announce the commencement of its buyback program with third-quarter earnings. The analyst has an Overweight rating and a $159 price target on...
PayPal Rises After BofA Upgrade to Buy, Analyst Sees Upside to EPS Estimates By Investing.com
© Reuters. PayPal Rises After BofA Upgrade to Buy, Analyst Sees Upside to EPS Estimates By Senad Karaahmetovic Shares of PayPal (NASDAQ:) are up over 4% after a Bank of America analyst upgraded to Buy from Neutral and hiked the price target to $114 from $94. The analyst highlights that he sees upside potential to...